サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1757976

人工血管の世界市場

Artificial Blood Vessels

出版日
ページ情報
英文 274 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
人工血管の世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 274 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工血管の世界市場は2030年までに3億7,950万米ドルに達する見込み

2024年に2億9,270万米ドルと推定される人工血管の世界市場は、分析期間2024-2030年にCAGR 4.4%で成長し、2030年には3億7,950万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるポリジオキサノンポリマーは、CAGR 5.4%を記録し、分析期間終了時には1億7,790万米ドルに達すると予測されます。エラストマーポリマーセグメントの成長率は、分析期間中CAGR 3.0％と推定されます。

米国市場は7,970万米ドルと推定、中国はCAGR 8.2％で成長予測

米国の人工血管市場は、2024年に7,970万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 8.2%で推移し、2030年には7,910万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8％と3.5％と予測されています。欧州では、ドイツがCAGR 2.6%で成長すると予測されています。

世界の人工血管市場- 主要動向と促進要因のまとめ

バイオエンジニアリング人工血管は心臓血管外科の未来か？

人工血管市場は、主に心臓血管や末梢動脈疾患における信頼性の高い人工血管の必要性によって、著しい勢いを増しています。合成血管や生物工学的に設計された血管は、特に天然の血管が移植に適さない患者において、血管外科手術に変革的な役割を果たしています。従来は発泡ポリテトラフルオロエチレン（ePTFE）やダクロンのような素材が主流であったが、現在では生来の血管の構造と機能を模倣した組織工学的人工血管（TEVG）へのシフトが見られます。これらの新しい人工血管は、生体適合性に優れ、血栓形成性が減少し、開存率が向上しています。3Dバイオプリンティングと足場作製の進歩は、カスタマイズの限界を押し広げ、外科的転帰を改善する患者特異的移植片を可能にしています。さらに、幹細胞技術と再生医療における技術革新は、宿主組織とシームレスに統合し、内皮化を促進する移植片の作成を可能にしています。このことは、子供とともに成長する血管再建を必要とする小児患者に特に有益です。ナノテクノロジーと表面改質の統合は、合成移植片の機械的強度と抗炎症特性をさらに高めています。さらに、脱細胞化された天然血管の調査により、天然組織の構造的完全性と滅菌移植片の安全性を併せ持つ既製ソリューションの新たな道が開かれつつあります。この分野は、バイオテクノロジー、材料科学、臨床医学の融合点にあり、心臓血管の修復と再建の未来に向けた大きな飛躍を示唆しています。

疾病負担の増大と外科的ニーズは市場の軌道にどのような影響を与えているか？

特に動脈硬化、動脈瘤、末梢動脈疾患などの心血管疾患（CVD）の世界の負担は、拡大する人工血管市場の強力な促進要因です。世界人口の高齢化は、座りがちなライフスタイルの増加や肥満・糖尿病率の上昇と相まって、しばしば外科的介入を必要とする血管合併症の急増に寄与しています。多くの場合、患者には移植に適した自己の静脈や動脈がないため、人工的な代用品は単にオプションではなく、不可欠なものとなっています。冠動脈バイパス移植術（CABG）や最終腎不全患者における血液透析アクセスは、人工グラフトが多用される最も一般的な用途の一つです。低侵襲血管手術を含む新しい手術手技は、柔軟で耐久性があり、適合性の高い人工グラフトへの需要を高めています。同時に、先進国・新興国を問わず、ヘルスケアシステムは複雑な血管インターベンションを実施する能力を拡大しつつあり、それによって手技量が増加し、ひいては器具の使用量も増加しています。さらに、軍民両者における外傷、先天性心疾患、大血管を伴う腫瘍切除により、使用事例が増加しています。低・中所得国では、手術インフラの改善と心臓治療への政府投資が市場浸透をさらに促進しています。緊急手術における信頼性の高い血管導管の必要性は、血管の健康に対する世界の意識の高まりと相まって、人工血管を最新の手術計画の最前線に位置づけています。

規制と臨床の課題がイノベーションの情勢を変えている？

技術の進歩にもかかわらず、人工血管市場は複雑な規制環境と臨床上の課題によって形成されています。血管移植片、特に組織工学的移植片や生体吸収性移植片に対する規制当局の承認プロセスは、心臓血管への応用というリスクの高い性質のため、極めて厳格です。安全性、耐久性、生体適合性、および長期的な有効性は、前臨床試験および多相臨床試験を通じて広範囲に実証されなければならないです。このため、製品開発期間が長期化し、コストが増大することが多く、実績のある医療機器企業や学術機関と提携しない限り、小規模なイノベーターの参入は制限されます。さらに、移植片の拒絶反応、感染リスク、動脈瘤の変性、小口径移植片（特に6mm以下）の開存性の制限といった問題は、臨床上の大きなハードルとなり続けています。このような課題から、合成足場と生物学的成分とを組み合わせ、免疫原性を低下させ、統合性を高めたハイブリッド移植片の開発を目指した研究が相次いでいます。トランスレーショナル・ギャップを克服し、臨床検証プロセスを合理化しようとする利害関係者の間で、バイオテクノロジー企業、大学、病院間の共同研究が一般的になりつつあります。さらに、市販後調査やバリューベースのヘルスケア指標の導入により、メーカーは長期転帰試験や実臨床エビデンスへの投資を余儀なくされています。世界の規模では、市場参入は、特に高額なグラフトコストが採用を制限しうる新興国において、様々な償還政策の影響を受けています。しかし、政府が支援するイノベーション・エコシステムと医療技術研究開発への民間投資の増加により、こうした力学は徐々に変化しており、より臨床的・商業的に実行可能な次世代人工血管の導入が可能になっています。

世界市場の成長を加速させている主な要因とは？

人工血管市場の成長は、臨床ニーズ、技術革新、ヘルスケア・インフラの拡大、治療パラダイムの変化に深く根ざしたいくつかの要因によって牽引されています。その中でも最も重要なのは、世界中で心臓血管や末梢血管の手術件数が増加していることです。これは、ライフスタイルに起因する慢性疾患や加齢に伴う血管変性の有病率が増加していることが大きな要因です。生分解性ポリマーや生物活性コーティングの開発など、バイオマテリアルの技術的進歩により、感染、血栓症、機械的疲労に強い人工血管の作製が可能になりました。3Dプリンティング、特にバイオプリンティングの急速な進歩により、個々の解剖学的構造に合わせたパーソナライズド移植片の製造が可能になり、合併症が減少し、手術の成功率が向上しています。慢性腎代替療法を受けている患者の間でバスキュラーアクセスソリューションに対する需要が高いことから、透析医療インフラの拡大も大きな成長促進要因となっています。さらに、特に新興市場では、人工グラフトを標準的な手術ツールキットに組み込む心臓血管専門センターが増えています。消費者の行動も一役買っており、早期外科的介入や高性能グラフトを必要とする低侵襲アプローチを選択する患者が増加しています。病院、研究機関、手術センターなどのエンドユーザーは、次世代移植片技術を共同開発するために、医療機器企業との提携をますます好むようになっています。さらに、遠隔医療や遠隔監視ツールの台頭により、術後管理が改善され、治療成績が向上し、人工グラフト使用に対する信頼が強まっています。これらの要因が相俟って、世界の人工血管市場は、持続的な技術革新、採用の増加、拡大成長の時期へと向かっています。

セグメント

ポリマー（ポリジオキサノンポリマー、エラストマーポリマー、ポリエチレンテレフタレートポリマー、その他ポリマー）、アプリケーション（大動脈疾患アプリケーション、末梢動脈疾患アプリケーション、血液透析アプリケーション）

調査対象企業の例（全34件）

  • Abbott Laboratories
  • ArtiCasc 3D
  • Artivion, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Getinge AB
  • Humacyte Inc.
  • Integra LifeSciences Holdings Corp.
  • Jiangsu Bioda Life Science Co., Ltd.
  • Johnson & Johnson
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Roumai Med
  • Smith & Nephew plc
  • Techshot Inc.
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36197

Global Artificial Blood Vessels Market to Reach US$379.5 Million by 2030

The global market for Artificial Blood Vessels estimated at US$292.7 Million in the year 2024, is expected to reach US$379.5 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Polydioxanone Polymer, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$177.9 Million by the end of the analysis period. Growth in the Elastomer Polymer segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$79.7 Million While China is Forecast to Grow at 8.2% CAGR

The Artificial Blood Vessels market in the U.S. is estimated at US$79.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$79.1 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Artificial Blood Vessels Market - Key Trends & Drivers Summarized

Are Bioengineered Vascular Grafts the Future of Cardiovascular Surgery?

The artificial blood vessels market is gaining remarkable momentum, primarily driven by the need for reliable vascular grafts in cardiovascular and peripheral artery diseases. Synthetic and bioengineered blood vessels are playing a transformative role in vascular surgeries, particularly in patients where natural vessels are unsuitable for grafting. Traditionally dominated by materials like expanded polytetrafluoroethylene (ePTFE) and Dacron, the market is now witnessing a shift toward tissue-engineered vascular grafts (TEVGs) that mimic the structure and function of native blood vessels. These newer grafts offer better biocompatibility, reduced thrombogenicity, and higher patency rates. Advances in 3D bioprinting and scaffold fabrication are pushing the boundaries of customization, enabling patient-specific grafts that improve surgical outcomes. Moreover, innovations in stem cell technology and regenerative medicine have made it possible to create grafts that integrate seamlessly with the host tissue and promote endothelialization. This is particularly beneficial in pediatric patients requiring vascular reconstructions that grow along with the child. The integration of nanotechnology and surface modifications is further enhancing the mechanical strength and anti-inflammatory properties of synthetic grafts. Additionally, research into decellularized natural vessels is opening new avenues for off-the-shelf solutions that combine the structural integrity of native tissues with the safety of sterilized grafts. The field is at the convergence of biotechnology, materials science, and clinical medicine, signaling a major leap toward the future of cardiovascular repair and reconstruction.

How Are Rising Disease Burdens and Surgical Needs Influencing Market Trajectories?

The global burden of cardiovascular diseases (CVDs), especially atherosclerosis, aneurysms, and peripheral arterial disease, is a powerful driver behind the expanding artificial blood vessels market. An aging global population, combined with increasingly sedentary lifestyles and rising rates of obesity and diabetes, is contributing to a surge in vascular complications that often necessitate surgical intervention. In many cases, patients lack suitable autologous veins or arteries for grafting, making artificial alternatives not just optional but essential. Coronary artery bypass grafting (CABG) and hemodialysis access in patients with end-stage renal disease are among the most common applications where artificial grafts are extensively used. Emerging surgical techniques, including minimally invasive vascular surgeries, are increasing the demand for flexible, durable, and highly compatible synthetic grafts. Simultaneously, healthcare systems across both developed and emerging nations are expanding their capabilities to perform complex vascular interventions, thereby increasing procedural volumes and, by extension, device utilization. Furthermore, traumatic injuries, congenital heart defects, and tumor resections involving major vessels in both military and civilian populations are creating additional use cases for artificial blood vessels. In low- and middle-income countries, improving surgical infrastructure and government investment in cardiac care are further stimulating market penetration. The need for reliable vascular conduits in emergency surgeries, coupled with greater global awareness of vascular health, is placing artificial blood vessels at the forefront of modern surgical planning.

Are Regulatory and Clinical Challenges Reshaping the Innovation Landscape?

Despite substantial technological advancement, the artificial blood vessels market remains shaped by a complex regulatory environment and significant clinical challenges. Regulatory approval processes for vascular grafts, particularly tissue-engineered and bioresorbable ones, are extremely rigorous due to the high-risk nature of cardiovascular applications. Safety, durability, biocompatibility, and long-term efficacy must be extensively demonstrated through preclinical and multi-phase clinical trials. This often extends product development timelines and increases costs, limiting the entry of smaller innovators unless they partner with established medical device companies or academic institutions. Furthermore, issues like graft rejection, infection risk, aneurysmal degeneration, and limited patency in small-diameter grafts-especially those under 6mm-continue to pose significant clinical hurdles. These challenges have fueled a wave of research aimed at developing hybrid grafts that combine synthetic scaffolds with biological components to reduce immunogenicity and enhance integration. Collaborations between biotech firms, universities, and hospitals are becoming more common as stakeholders seek to overcome translational gaps and streamline clinical validation processes. Additionally, the implementation of post-market surveillance and value-based healthcare metrics is forcing manufacturers to invest in long-term outcome studies and real-world evidence. On a global scale, market access is influenced by variable reimbursement policies, particularly in emerging economies where high graft costs can limit adoption. However, government-supported innovation ecosystems and rising private investment in medtech R&D are slowly shifting these dynamics, enabling the introduction of next-generation vascular grafts with better clinical and commercial viability.

What Key Forces Are Accelerating Global Market Growth?

The growth in the artificial blood vessels market is driven by several factors that are deeply rooted in clinical needs, technological innovation, healthcare infrastructure expansion, and shifting treatment paradigms. Foremost among these is the increasing number of cardiovascular and peripheral vascular surgeries being performed worldwide, due in large part to the growing prevalence of lifestyle-induced chronic diseases and age-related vascular degeneration. Technological progress in biomaterials, such as the development of biodegradable polymers and bioactive coatings, has enabled the creation of artificial vessels that better resist infection, thrombosis, and mechanical fatigue. Rapid advancements in 3D printing, particularly bioprinting, are making it feasible to manufacture personalized grafts tailored to individual anatomy, thus reducing complications and improving surgical success rates. The expansion of dialysis care infrastructure is another major growth driver, given the high demand for vascular access solutions among patients undergoing chronic renal replacement therapy. Additionally, a growing number of specialized cardiovascular centers, especially in emerging markets, are incorporating artificial grafts into their standard surgical toolkits. Consumer behavior is also playing a role, with patients increasingly opting for early surgical intervention and minimally invasive approaches that require high-performance grafts. End-users, including hospitals, research institutions, and surgical centers, are increasingly favoring partnerships with medical device firms to co-develop next-gen graft technologies. Furthermore, the rise of telehealth and remote monitoring tools is enabling better post-operative management, improving outcomes and reinforcing confidence in artificial graft use. Collectively, these factors are propelling the global artificial blood vessels market toward a period of sustained innovation, rising adoption, and expansive growth.

SCOPE OF STUDY:

The report analyzes the Artificial Blood Vessels market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Polymer (Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer, Other Polymers); Application (Aortic Disease Application, Peripheral Artery Disease Application, Hemodialysis Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • ArtiCasc 3D
  • Artivion, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Getinge AB
  • Humacyte Inc.
  • Integra LifeSciences Holdings Corp.
  • Jiangsu Bioda Life Science Co., Ltd.
  • Johnson & Johnson
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Roumai Med
  • Smith & Nephew plc
  • Techshot Inc.
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Blood Vessels - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Vascular Grafts in Cardiovascular Surgery Throws the Spotlight on Artificial Blood Vessels
    • Development of Biocompatible and Non-Thrombogenic Materials Improves Graft Longevity
    • Use in Coronary, Peripheral, and Dialysis-Related Procedures Sustains Diverse Clinical Demand
    • Advances in Electrospinning and Tissue Engineering Enable Scaffold-Free Vessel Fabrication
    • Focus on Small-Diameter Vessels Expands Possibilities in Coronary Applications
    • Increase in Endovascular and Minimally Invasive Techniques Spurs Compatibility Requirements
    • Integration With Drug-Eluting and Anti-Infection Coatings Enhances Post-Operative Outcomes
    • Expansion of Organ Transplant and Bypass Surgeries Drives Hospital Procurement
    • Longitudinal Studies Strengthen Evidence Base and Regulatory Confidence
    • Growing Interest in Personalized and 3D-Printed Vascular Grafts Supports Tailored Therapies
    • Use in Pediatric and Congenital Applications Highlights Unmet Needs in Niche Segments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Blood Vessels Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Blood Vessels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polydioxanone Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polydioxanone Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Polydioxanone Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Elastomer Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Elastomer Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Elastomer Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Polyethylene Terephthalate Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Polyethylene Terephthalate Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Polyethylene Terephthalate Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Polymers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Aortic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Aortic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Aortic Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Artery Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Peripheral Artery Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Peripheral Artery Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hemodialysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hemodialysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hemodialysis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • CHINA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Artificial Blood Vessels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Artificial Blood Vessels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • INDIA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Artificial Blood Vessels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Artificial Blood Vessels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030

IV. COMPETITION